TGFB1 and neoplasm: Moreover, Tregs can not only interact directly with T cells and NK cells, but also indirectly inhibit the anti-tumor activity of T cells and NK cells through producing immunomodulatory cytokines such as IL-10 and TGF-β (Liu Y. et al., 2022).